Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: New therapeutic opportunities

Luca Arcaini; Davide Rossi

doi:10.3324/haematol.2011.058362

Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: New therapeutic opportunities

Luca Arcaini, Davide Rossi

Research output: Contribution to journal › Editorial

Abstract

Comment on BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. [Haematologica. 2012]

Original language	English
Pages (from-to)	638-640
Number of pages	3
Journal	Haematologica
Volume	97
Issue number	5
DOIs	https://doi.org/10.3324/haematol.2011.058362
Publication status	Published - 1 May 2012
Externally published	Yes

Access to Document

10.3324/haematol.2011.058362

Cite this

@article{51c4bafc7a6e48ae9babdd9dba302e16,

title = "Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: New therapeutic opportunities",

abstract = "Comment on BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. [Haematologica. 2012]",

author = "Luca Arcaini and Davide Rossi",

year = "2012",

month = may,

day = "1",

doi = "10.3324/haematol.2011.058362",

language = "English",

volume = "97",

pages = "638--640",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "5",

}

TY - JOUR

T1 - Nuclear factor-κB dysregulation in splenic marginal zone lymphoma

T2 - New therapeutic opportunities

AU - Arcaini, Luca

AU - Rossi, Davide

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Comment on BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. [Haematologica. 2012]

AB - Comment on BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. [Haematologica. 2012]

UR - http://www.scopus.com/inward/record.url?scp=84860563311&partnerID=8YFLogxK

U2 - 10.3324/haematol.2011.058362

DO - 10.3324/haematol.2011.058362

M3 - Editorial

SN - 0390-6078

VL - 97

SP - 638

EP - 640

JO - Haematologica

JF - Haematologica

IS - 5

ER -

Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: New therapeutic opportunities

Abstract

Access to Document

Other files and links

Fingerprint

Cite this